These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 14575894)
1. Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor. Kagamiishi Y; Yamamoto T; Watanabe S Brain Res; 2003 Nov; 991(1-2):212-21. PubMed ID: 14575894 [TBL] [Abstract][Full Text] [Related]
2. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains. Conti LH Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor. Dedeoğlu A; Fisher LA Am J Physiol; 1994 Sep; 267(3 Pt 2):R859-64. PubMed ID: 8092332 [TBL] [Abstract][Full Text] [Related]
4. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system. Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718 [TBL] [Abstract][Full Text] [Related]
5. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. Price ML; Lucki I J Neurosci; 2001 Apr; 21(8):2833-41. PubMed ID: 11306635 [TBL] [Abstract][Full Text] [Related]
6. The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor. Ohmura Y; Izumi T; Yamaguchi T; Tsutsui-Kimura I; Yoshida T; Yoshioka M Neuropsychopharmacology; 2010 May; 35(6):1271-8. PubMed ID: 20072117 [TBL] [Abstract][Full Text] [Related]
7. Prenatal ethanol exposure alters sensitivity to the effects of corticotropin-releasing factor (CRF) on behavior in the elevated plus-maze. Gabriel KI; Yu CL; Osborn JA; Weinberg J Psychoneuroendocrinology; 2006 Oct; 31(9):1046-56. PubMed ID: 16934947 [TBL] [Abstract][Full Text] [Related]
8. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Fujii T; Yoshizawa M; Nakai K; Fujimoto K; Suzuki T; Kawashima K Brain Res; 1997 Jul; 761(2):244-9. PubMed ID: 9252022 [TBL] [Abstract][Full Text] [Related]
9. Effects of 5-HT-1A receptor agonists on CRF-induced behavior. Lazosky AJ; Britton DR Psychopharmacology (Berl); 1991; 104(1):132-6. PubMed ID: 1831906 [TBL] [Abstract][Full Text] [Related]
10. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system. Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718 [TBL] [Abstract][Full Text] [Related]
11. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus. Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404 [TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. Lukkes JL; Forster GL; Renner KJ; Summers CH Eur J Pharmacol; 2008 Jan; 578(2-3):185-93. PubMed ID: 17945210 [TBL] [Abstract][Full Text] [Related]
13. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Price ML; Kirby LG; Valentino RJ; Lucki I Psychopharmacology (Berl); 2002 Aug; 162(4):406-14. PubMed ID: 12172694 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066 [TBL] [Abstract][Full Text] [Related]
16. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606 [TBL] [Abstract][Full Text] [Related]
17. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. Braida D; Limonta V; Malabarba L; Zani A; Sala M Eur J Pharmacol; 2007 Jan; 555(2-3):156-63. PubMed ID: 17116299 [TBL] [Abstract][Full Text] [Related]
18. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348 [TBL] [Abstract][Full Text] [Related]
19. Effects of corticotropin-releasing factor on brain serotonergic activity. Price ML; Curtis AL; Kirby LG; Valentino RJ; Lucki I Neuropsychopharmacology; 1998 Jun; 18(6):492-502. PubMed ID: 9571657 [TBL] [Abstract][Full Text] [Related]
20. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment. Santucci AC; Madeira E Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]